NLS BICO

BICO has acquired all the shares in San Diego-based Allegro 3D for an up-front enterprise value of USD 6 million. Additionally, the shareholders can receive USD 5 million in an earnout payment contingent on Allegro 3D’s financial performance in the coming two years. The entire purchase price will be paid in cash. Allegro 3D’s patented […]

BICO has been awarded this year’s SwedenBIO Award for showcasing the power of the Swedish life-science industry on the global arena and its visionary business model and remarkable growth. The bio convergence company, BICO, has received SwedenBIO’s Award which was announced in connection with SwedenBIO’s Annual Summit in Stockholm. Presented for the last fifteen years, […]

Deloitte recognizes BICO as the third fastest-growing company in Sweden in the annual Technology Fast 50 ranking. Deloitte’s annual ranking acknowledges the 50 fastest-growing technology companies based on revenue growth over the last four years. “The recognition is a confirmation of our rapid global growth and of the potential and interest for our bio convergence […]

BICO has added Susan Tousi to its Board of Directors. Tousi has spent nearly a decade at Illumina, where she currently leads the global commercial organization. Tousi was approved unanimously during an Extraordinary General Meeting (EGM) of the Board of Directors. As the leader of Illumina’s commercial organization, Tousi will bring invaluable strategic insights and […]

BICO has acquired all outstanding shares in Advanced BioMatrix, an American company focusing on 3D research applications. The Advanced BioMatrix portfolio includes collagen bioinks, high purity extracellular matrix proteins, chemically modified proteins and polysaccharides, and other reagents and cell assays, sold to research institutions, and pharmaceutical and biotech companies. The company has a particularly strong […]